Outlook Therapeutics (OTLK) EBITDA Margin (QoQ) (2015 - 2025)
Outlook Therapeutics (OTLK) EBITDA Margin (QoQ) (2015 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Outlook Therapeutics | 88.50 Mn | 77.26 Mn | -8,265.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 1.99 Mn |
| Sep 30, 2019 | 74,989.00 |
| Jun 30, 2019 | 23,515.00 |
| Mar 31, 2019 | -24,108.00 |
| Dec 31, 2018 | 64,743.00 |
| Sep 30, 2018 | -67,286.00 |
| Jun 30, 2018 | -5,038.00 |
| Mar 31, 2018 | -47,303.00 |
| Dec 31, 2017 | -31,165.00 |
| Sep 30, 2017 | 231,985.00 |
| Jun 30, 2017 | 16,546.00 |
| Mar 31, 2017 | 328,470.00 |
| Dec 31, 2016 | -385,927.00 |
| Sep 30, 2016 | 243,992.00 |
| Jun 30, 2016 | -415,404.00 |
| Mar 31, 2016 | 135,284.00 |
| Dec 31, 2015 | 186,048.00 |
| Sep 30, 2015 | -265,720.00 |
| Jun 30, 2015 | 197,620.00 |